Forward genetic screen of human transposase genomic rearrangements
Anton G. Henssen(Charité - Universitätsmedizin Berlin), Alex Kentsis(Memorial Sloan Kettering Cancer Center)
Cited by 0
Related Papers
Peptidomimetic blockade of MYB in acute myeloid leukemia
|Nature Communications|2018|95
Prohibitin promotes dedifferentiation and is a potential therapeutic target in neuroblastoma
|JCI Insight|2019|33
Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms’ tumor
|JCI Insight|2019|29
Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models
|Molecular Cancer Therapeutics|2023|17
Passenger Gene Coamplifications Create Collateral Therapeutic Vulnerabilities in Cancer
|Cancer Discovery|2024|16